I

Intuitive Surgical

Builds robots for minimally invasive surgery

Indirect Procurement Operations Analyst

Full-TimePosted on 10/23/2026
No salary listed
Mid, Senior
Bachelor's
Mexicali, Baja California, Mexico
In PersonOnsite in a standard office environment; occasional travel may be required.
Operations & LogisticsProcurement & Sourcing

About the job

Requirements
  • Two to five years of relevant experience in procurement, purchasing operations, supply chain, procure-to-pay, shared services, or a related operational function.
  • Working knowledge of indirect procurement and procure-to-pay processes, including purchase requisitions, purchase orders, approval workflows, supplier onboarding, and transaction exceptions.
  • Ability to review purchasing requests and supporting documentation for completeness, accuracy, and alignment with established requirements.
  • Strong analytical and problem-solving skills, including the ability to investigate process or system issues and coordinate practical resolutions.
  • Strong customer service and stakeholder-management skills, with the ability to provide guidance while applying policies and controls consistently.
  • Effective written and verbal communication skills, with the ability to document decisions and tailor communication to different audiences.
  • Ability to manage multiple assignments, shifting priorities, and time-sensitive requests while maintaining accuracy.
  • Proficiency with procurement or enterprise systems such as Coupa, SAP, Oracle, or Ariba.
  • Proficiency with Microsoft 365 applications, particularly Excel, Word, PowerPoint, and Outlook, and with virtual collaboration tools such as Zoom.
  • Experience using reporting and workflow tools such as Tableau, Power BI, and Smartsheet to track, analyze, and report operational information.
  • Familiarity with AI-enabled productivity tools and willingness to apply them to improve accuracy, efficiency, and communication.
  • Ability to collaborate effectively with cross-functional and regional teams.
  • Proficiency in written and spoken English appropriate for a global business environment.
  • A bachelor's degree in Business Administration, Supply Chain Management, Procurement, Finance, Operations, or a related field, or an equivalent combination of relevant education and professional experience.
  • Completion of company-required training related to procurement systems, policies, compliance, information security, and applicable operational procedures.
Responsibilities
  • Review and approve assigned purchase requisitions across applicable request types, confirming that business information, supporting documentation, and required approvals are complete and accurate.
  • Evaluate transactions against applicable procurement policies and approval requirements, and address incomplete or inconsistent requests through clarification, return, or escalation as appropriate.
  • Determine when requests require input from Sourcing, Contracts, Legal, Finance, Accounts Payable, Regulatory, Supplier Enablement, Information Technology, or other functional partners, and support the appropriate routing and handoffs.
  • Review purchase order change requests and support supplier onboarding, supplier updates, purchase order maintenance, and other assigned procure-to-pay activities.
  • Investigate and resolve operational issues affecting purchase orders, invoices, and related transactions, coordinating corrective actions with stakeholders and functional partners.
  • Respond to procurement inquiries through approved support channels, providing clear and timely guidance and managing follow-up actions through resolution.
  • Manage assigned work in line with established service expectations and team KPIs, monitoring assigned queues, prioritizing time-sensitive requests, and communicating status and potential delays.
  • Support the development and maintenance of process documentation, templates, and training materials, and identify recurring issues and opportunities to improve efficiency, consistency, and the stakeholder experience.
Desired Qualifications
  • Experience reviewing complex indirect purchasing transactions involving services, software, capital equipment, statements of work, blanket purchase orders, catalogs, or punchout suppliers.
  • Experience with Coupa Procure-to-Pay and SAP or a comparable ERP environment.
  • Familiarity with approval-authority controls, contract documentation requirements, supplier onboarding, payment terms, and procurement compliance.
  • Experience investigating purchase order, invoice, approval-routing, or supplier data exceptions.
  • Experience developing or maintaining work instructions, standard operating procedures, quick reference guides, process maps, or training materials.
  • Experience using operational metrics, dashboards, or transaction data to identify trends and improvement opportunities.
  • Experience supporting global or regional procurement operations in a cross-functional environment.
  • Professional certification or coursework in procurement, supply chain, process improvement, data analytics, or project management.

About the company

Intuitive Surgical makes da Vinci robots that let surgeons operate through a few small incisions, and Ion, a robot that reaches deep into the lungs to take tissue samples. In 2000, da Vinci became the first robotic system cleared by the FDA for general laparoscopic surgery, meaning keyhole operations in the abdomen. A surgeon sits at a nearby console and steers robotic arms holding a 3D camera and wristed instruments, which turn hand movements into smaller, steadier motions. Hospitals buy or lease the robots, then keep paying for the instruments used in each operation and for service. Intuitive was founded in 1995 to commercialize robotic surgery research from SRI International and is based in Sunnyvale, California.

Company Size

10,001+

Company Stage

IPO

Headquarters

Sunnyvale, California

Founded

1995

Get referred to Intuitive Surgical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Demand keeps compounding: da Vinci procedures grew 15% and revenue 19%, to $2.89 billion, in the June 2026 quarter.
  • Room to grow: Intuitive listed 748 open roles in October 2026, including 191 in engineering and 312 in Sunnyvale.
  • Repeat sales steady the business: instruments and service made 76% of revenue in the June 2026 quarter.

What critics are saying

  • Stock grants have shrunk: shares fell 27% from January to October 2026, versus 9% for rival Medtronic.
  • Device giants are moving in: the FDA cleared rival robots from Medtronic in December 2025 and J&J in July 2026.
  • Instrument sales face a court fight: in August 2026, an appeals court revived a repair firm's monopoly suit against Intuitive.

What makes Intuitive Surgical unique

  • Hospitals rent more than they buy: 254 of 468 da Vinci systems placed in the June 2026 quarter were leases.
  • It runs without borrowing: Intuitive had no debt and $8.6 billion in cash and investments in June 2026.
  • Its CEO is a 30-year insider: Dave Rosa, CEO since July 2025, joined as employee number nine in 1996.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Oct 1st, 2026
Intuitive Surgical down 30% in 2026, but Wall Street analysts stay bullish

Intuitive Surgical has lost nearly 30% year-to-date in 2026, making it one of healthcare's biggest losers. The stock fell over 40% by late July. Despite this decline, Wall Street remains bullish—24 of 32 analysts surveyed by S&P Global in September rated it a "buy" or "strong buy." The medical device maker faces several challenges. Growth is slowing whilst the stock trades at a forward price-to-earnings multiple over 33. Competition in China remains difficult, and the company now battles healthcare giants Johnson & Johnson, Medtronic, and Stryker in robotic surgical systems. The expiration of Affordable Care Act subsidies and rising GLP-1 drug usage have also impacted procedure volumes. However, the company's Asian revenue still jumped 20% year-over-year in Q2, suggesting these headwinds aren't insurmountable.

Yahoo Finance
Sep 17th, 2026
Intuitive Surgical, IonQ, and Accenture hold billions in net cash for growth

Investors seeking financial stability often look to companies with more cash than debt, as these businesses have greater flexibility for growth investments, buybacks, and dividends. Intuitive Surgical holds $5.22 billion in net cash. The robotic surgery pioneer achieved 20.7% annual revenue growth over the past two years, whilst its earnings per share increased 17.4% annually over five years. IonQ maintains $2.06 billion in net cash, representing 14.1% of its market capitalisation. The quantum computing company posted 181% annual revenue growth over two years and expects 163% growth next year. Accenture has $1.78 billion in net cash. The professional services firm employs approximately 774,000 people across more than 120 countries. Companies with strong balance sheets can navigate uncertain markets whilst pursuing expansion opportunities without the burden of significant debt obligations.

Yahoo Finance
Aug 23rd, 2026
Thermo Fisher vs Intuitive Surgical: which premium healthcare stock justifies valuation?

Thermo Fisher and Intuitive Surgical both delivered strong recent quarters, but their premium valuations rest on different foundations. Thermo Fisher's case depends on recovery in life sciences spending after the pandemic slowdown. The company's Life Sciences Solutions segment saw reported revenue climb 13% year-over-year, with organic revenue up 3%. The Analytical Instruments business returned to growth after nearly two years of weak demand, suggesting laboratory spending is normalising. Intuitive Surgical maintains its premium through business model strength. The company's non-GAAP gross profit margin reached 70.0%, whilst its non-GAAP operating margin expanded 330 basis points year-over-year to 42.1%. Recurring revenue streams constitute roughly 85% of total sales. Intuitive placed 468 da Vinci surgical units in fiscal Q2, marking 18% year-over-year growth, indicating continued hospital investment in robotic surgery platforms.

Yahoo Finance
Aug 19th, 2026
Abbott beats Q2 estimates with 13% sales growth as diagnostics surge 42%, while Intuitive Surgical posts 19% revenue rise

Abbott Laboratories reported strong fiscal Q2 2026 results, with sales rising 13% on a reported basis and 4.8% on a comparable basis, beating estimates and prompting the company to raise its annual profit forecast. The diagnostics segment was particularly strong, growing 42% to $3.09 billion, driven by its cancer diagnostics business following the Exact Sciences acquisition. Intuitive Surgical also exceeded expectations in Q2 2026, with revenue growing 19% to $2.89 billion and adjusted EPS of $2.80, beating forecasts by $0.30. The company placed 468 da Vinci units during the quarter, an 18% year-over-year increase, whilst maintaining a non-GAAP gross margin of 70.0%. The companies present contrasting investment cases: Abbott offers diversified healthcare portfolio resilience, whilst Intuitive Surgical relies on its robotic surgery ecosystem with recurring revenue comprising approximately 85% of total sales.

PR Newswire
Aug 17th, 2026
Intuitive leases 316,000-sq-ft facility in Penang to manufacture surgical instruments, create 1,200 jobs by 2032

Intuitive, the global leader in minimally invasive care and pioneer of robotic-assisted surgery, has signed a lease agreement with Penang Development Corporation for a new manufacturing facility in Malaysia. The 316,000-square-foot site in Bandar Cassia Technology Park will produce surgical instruments and electromechanical devices for Intuitive's da Vinci surgical system. The facility is expected to begin operations in 2028 and create 1,200 highly skilled jobs by 2032. The investment reflects Intuitive's commitment to Asia Pacific, where its da Vinci systems have treated more than 2.5 million patients across 13 markets over two decades. The expansion aims to support growing demand for robotic-assisted surgery across the region and strengthen Penang's position as a MedTech manufacturing hub in Southeast Asia.